Showing results (11-20 of 237) with videos related to
Sort By:
Pageof 24
Receptor|January 1, 1992
Occupancy-response relationships for beta- and alpha 2-adrenergic receptors exerting opposing effects on cAMP productionB N Atkinson, K P MinnemanScience and Engineering Ethics|August 25, 2007
Virtue blindness and hegemony: qualitative evidence of negotiated ethical frameworks in the social language of university research administrationTimothy N Atkinson, Diane S GillelandJournal of Neurochemistry|February 1, 1991
Multiple adrenergic receptor subtypes controlling cyclic AMP formation: comparison of brain slices and primary neuronal and glial culturesB N Atkinson, K P MinnemanFood Additives and Contaminants|May 1, 1995
Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: lack of associationD P Hsieh, D N AtkinsonAdvances in Experimental Medicine and Biology|January 1, 1991
Bisfuranoid mycotoxins: their genotoxicity and carcinogenicityD P Hsieh, D N AtkinsonBiometrics|September 1, 1985
Confidence limits for probability of response in multistage phase II clinical trialsE N Atkinson, B W BrownArchives of Neurology|May 1, 1984
Cerebral arteritis and bacterial meningitisM Igarashi, R C Gilmartin, B Gerald, et al.Journal of Clinical Pharmacology|October 15, 2009
Lack of electrocardiographic effect of dexlansoprazole MR, a novel modified-release formulation of the proton pump inhibitor dexlansoprazole, in healthy participantsMajid Vakily, Jingtao Wu, Stuart N AtkinsonThe New Zealand Medical Journal|September 18, 2008
Ethnic counts on mortality and census data (mostly) agree for 2001-2004: New Zealand Census-Mortality Study updateTony Blakely, June N Atkinson, Jackie FawcettJournal of Clinical Pharmacology|March 26, 2009
Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjectsWeijiang Zhang, Jingtao Wu, Stuart N AtkinsonPageof 24